Matrix Global Advisors
  • Home
  • About
  • News
  • Reports
  • Contact
  • Follow
  • Follow
Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded

Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded

May 12, 2022 | Analysis

Alex Brill to FTC: Claims That PBMs Raise Drug Prices are Unfounded MGA’s Alex Brill submitted a letter in response to a request for information from the Federal Trade Commission. The FTC was looking for information regarding the business practices of pharmacy benefit...
New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition

New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition

Mar 1, 2022 | Analysis

New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition MGA has released a new report today, “Understanding Drug Rebates and Their Role in Promoting Competition,” authored by founder and CEO Alex Brill. Offering new analysis on the...
Conservative Thinkers Share Their Views for Biosimilars in a Post-ACA, BPCIA Landscape

Conservative Thinkers Share Their Views for Biosimilars in a Post-ACA, BPCIA Landscape

Jul 24, 2019 | News

Conservative Thinkers Share Their Views for Biosimilars in a Post-ACA, BPCIA Landscape Allison Inserro | The Center for Biosimilars “Would legislators take the opportunity to redo some parts of the BPCIA, if they had the chance? Both [Alex] Brill and Hayes said...
  • Analysis (38)
  • Books (3)
  • Events (15)
  • Interviews (48)
  • News (51)
  • Op-Eds (80)
  • Press Releases (4)
  • Testimony (20)
  • Health Care Workforce Shortages
    Health Care Workforce Shortages: An Updated LookFebruary 21, 2023
  • New MGA Analysis of the Adalimumab Biosimilars Market in the United StatesFebruary 21, 2023
  • Squawk Box tax policy
    MGA’s Alex Brill on CNBC’s Squawk Box Discussing the Recent Tax Policy ProposalFebruary 13, 2023
  • Curb Drug Patent Abuse
    Bipartisan Senate Bill Aims to Curb Drug Patent AbuseFebruary 1, 2023
  • Humira rivals drive down cost
    Humira Rivals Set to Try to Drive Down Cost of Blockbuster DrugJanuary 31, 2023
  • patent thickets lost drug savings
    New Report from MGA Examines the One-Year Cost Savings Lost Due to Patent ThicketsJanuary 26, 2023
  • Biosimilar Coverage in Commercial
    New MGA Analysis of Biosimilar Coverage in Commercial Medical BenefitDecember 8, 2022
  • Narrow House GOP Victory
    Narrow House GOP Victory Should Point Toward Policy Development AgendaDecember 6, 2022
  • Health Care Workforce Shortages
    Don’t Let Pandemic Fatigue Inhibit Pandemic PreparednessNovember 15, 2022
  • Pro-Growth Tax System.
    American Renewal: A Simpler, More Responsible, and Pro-Growth Tax SystemNovember 15, 2022
© Copyright 2022 Matrix Global Advisors | Design By DreamBig Creative
MGA
  • Home
  • About
  • News
  • Reports
  • Contact